Haemonetics Corporation (HAE) dropped 23.96 percent to $57.62 on Thursday after reporting weaker-than-expected second-quarter results.
Net revenues fell to $321.4 million from $336.2 million a year ago, while net income declined to $34.0 million from $38.4 million.
The stock opened at $72.08 and traded between $56.70 and $72.00 during the session, with volume soaring to 3.7 million shares versus an average of around 562,000 on the New York Stock Exchange. Shares are now hovering just above the 52-week low of $55.30, well below the high of $94.99.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.